{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T07:27:23Z","timestamp":1769585243753,"version":"3.49.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T00:00:00Z","timestamp":1511136000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00213-017-4779-2","type":"journal-article","created":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T02:54:58Z","timestamp":1511146498000},"page":"561-571","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Progress and promise for the MDMA drug development program"],"prefix":"10.1007","volume":"235","author":[{"given":"Allison A.","family":"Feduccia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Holland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael C.","family":"Mithoefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,20]]},"reference":[{"key":"4779_CR1","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1177\/0269881116642542","volume":"30","author":"T Amoroso","year":"2016","unstructured":"Amoroso T, Workman M (2016) Treating posttraumatic stress disorder with MDMA-assisted psychotherapy: a preliminary meta-analysis and comparison to prolonged exposure therapy. J Psychopharmacol 30:595\u2013600. https:\/\/doi.org\/10.1177\/0269881116642542","journal-title":"J Psychopharmacol"},{"key":"4779_CR2","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.biopsych.2010.08.003","volume":"68","author":"G Bedi","year":"2010","unstructured":"Bedi G, Hyman D, de Wit H (2010) Is ecstasy an \"empathogen\"? Effects of +\/\u22123,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others. Biol Psychiatry 68:1134\u20131140. https:\/\/doi.org\/10.1016\/j.biopsych.2010.08.003","journal-title":"Biol Psychiatry"},{"key":"4779_CR3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00213-009-1635-z","volume":"207","author":"G Bedi","year":"2009","unstructured":"Bedi G, Phan KL, Angstadt M, de Wit H (2009) Effects of MDMA on sociability and neural response to social threat and social reward. Psychopharmacology 207:73\u201383","journal-title":"Psychopharmacology"},{"key":"4779_CR4","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1177\/0269881116663120","volume":"30","author":"AK Bershad","year":"2016","unstructured":"Bershad AK, Miller MA, Baggott MJ, de Wit H (2016a) The effects of MDMA on socio-emotional processing: does MDMA differ from other stimulants? J Psychopharmacol 30:1248\u20131258. https:\/\/doi.org\/10.1177\/0269881116663120","journal-title":"J Psychopharmacol"},{"key":"4779_CR5","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1080\/17470919.2016.1143026","volume":"11","author":"AK Bershad","year":"2016","unstructured":"Bershad AK, Weafer JJ, Kirkpatrick MG, Wardle MC, Miller MA, de Wit H (2016b) Oxytocin receptor gene variation predicts subjective responses to MDMA. Soc Neurosci 11:592\u2013599. https:\/\/doi.org\/10.1080\/17470919.2016.1143026","journal-title":"Soc Neurosci"},{"key":"4779_CR6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/02791072.2008.10400637","volume":"40","author":"JC Bouso","year":"2008","unstructured":"Bouso JC, Doblin R, Farre M, Alcazar MA, Gomez-Jarabo G (2008) MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder. J Psychoactive Drugs 40:225\u2013236","journal-title":"J Psychoactive Drugs"},{"key":"4779_CR7","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1176\/appi.ajp.162.2.214","volume":"162","author":"R Bradley","year":"2005","unstructured":"Bradley R, Greene J, Russ E, Dutra L, Westen D (2005) A multidimensional meta-analysis of psychotherapy for PTSD. Am J Psychiatry 162:214\u2013227. https:\/\/doi.org\/10.1176\/appi.ajp.162.2.214","journal-title":"Am J Psychiatry"},{"key":"4779_CR8","first-page":"1837","volume":"283","author":"K Brady","year":"2000","unstructured":"Brady K, Pearlstein T, Asnis GM, Baker D, Rothbaum B, Sikes CR (2000) Farfel GM. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial JAMA 283:1837\u20131844","journal-title":"Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial JAMA"},{"key":"4779_CR9","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.biopsych.2013.12.015","volume":"78","author":"RL Carhart-Harris","year":"2015","unstructured":"Carhart-Harris RL et al (2015) The effects of acutely administered 3,4-methylenedioxymethamphetamine on spontaneous brain function in healthy volunteers measured with arterial spin labeling and blood oxygen level-dependent resting state functional connectivity. Biol Psychiatry 78:554\u2013562. https:\/\/doi.org\/10.1016\/j.biopsych.2013.12.015","journal-title":"Biol Psychiatry"},{"key":"4779_CR10","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1017\/S1461145713001405","volume":"17","author":"RL Carhart-Harris","year":"2014","unstructured":"Carhart-Harris RL et al (2014) The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memories. Int J Neuropsychopharmacol 17:527\u2013540. https:\/\/doi.org\/10.1017\/S1461145713001405","journal-title":"Int J Neuropsychopharmacol"},{"key":"4779_CR11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0149-7634(05)80176-9","volume":"16","author":"CS Carter","year":"1992","unstructured":"Carter CS (1992) Oxytocin and sexual behavior. Neurosci Biobehav Rev 16:131\u2013144","journal-title":"Neurosci Biobehav Rev"},{"key":"4779_CR12","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0006-3223(01)01083-6","volume":"50","author":"B Chen","year":"2001","unstructured":"Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT (2001) Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 50:260\u2013265","journal-title":"Biol Psychiatry"},{"key":"4779_CR13","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/psyp.12327","volume":"52","author":"CM Clark","year":"2015","unstructured":"Clark CM, Frye CG, Wardle MC, Norman GJ, de Wit H (2015) Acute effects of MDMA on autonomic cardiac activity and their relation to subjective prosocial and stimulant effects. Psychophysiology 52:429\u2013435. https:\/\/doi.org\/10.1111\/psyp.12327","journal-title":"Psychophysiology"},{"key":"4779_CR14","unstructured":"Cohen DB (2015) Countering the dynamics of dominance: how therapists create safety through egalitarianism in MDMA-assisted psychotherapy for women veterans with complex posttraumatic stress disorder. Dissertation, California Institute of Integral Studies"},{"key":"4779_CR15","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1939-0025.2012.01154.x","volume":"82","author":"W D\u2019Andrea","year":"2012","unstructured":"D\u2019Andrea W, Ford J, Stolbach B, Spinazzola J, van der Kolk BA (2012) Understanding interpersonal trauma in children: why we need a developmentally appropriate trauma diagnosis. Am J Orthop 82:187\u2013200. https:\/\/doi.org\/10.1111\/j.1939-0025.2012.01154.x","journal-title":"Am J Orthop"},{"key":"4779_CR16","first-page":"30","volume":"23","author":"A Danforth","year":"2013","unstructured":"Danforth A (2013) Findings from a collective case study of the MDMA\/ecstasy experiences of adults on the autism spectrum: transcripts from psychedelic science 2013 MAPS. Bulletin 23:30\u201335","journal-title":"Bulletin"},{"key":"4779_CR17","doi-asserted-by":"publisher","unstructured":"Danforth AL, Struble CM, Yazar-Klosinski B, Grob CS (2015) MDMA-assisted therapy: a new treatment model for social anxiety in autistic adults Prog Neuropsychopharmacol Biol Psychiatry doi: https:\/\/doi.org\/10.1016\/j.pnpbp.2015.03.011","DOI":"10.1016\/j.pnpbp.2015.03.011"},{"key":"4779_CR18","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0006-3223(02)01458-0","volume":"52","author":"RJ Davidson","year":"2002","unstructured":"Davidson RJ et al (2002) Neural and behavioral substrates of mood and mood regulation. Biol Psychiatry 52:478\u2013502","journal-title":"Biol Psychiatry"},{"key":"4779_CR19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1749-6632.2000.tb05199.x","volume":"914","author":"R Torre de la","year":"2000","unstructured":"de la Torre R et al (2000) Pharmacology of MDMA in humans. Ann N Y Acad Sci 914:225\u2013237","journal-title":"Ann N Y Acad Sci"},{"key":"4779_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2012.00235","volume":"3","author":"R Torre de la","year":"2012","unstructured":"de la Torre R, Yubero-Lahoz S, Pardo-Lozano R, Farre M (2012) MDMA, methamphetamine, and CYP2D6 pharmacogenetics: what is clinically relevant? Front Genet 3:235. https:\/\/doi.org\/10.3389\/fgene.2012.00235","journal-title":"Front Genet"},{"key":"4779_CR21","doi-asserted-by":"publisher","unstructured":"Dolder PC, Muller F, Schmid Y, Borgwardt SJ, Liechti ME (2017) Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects Psychopharmacology (Berl) doi: https:\/\/doi.org\/10.1007\/s00213-017-4650-5","DOI":"10.1007\/s00213-017-4650-5"},{"key":"4779_CR22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/17470910802649470","volume":"4","author":"GJ Dumont","year":"2009","unstructured":"Dumont GJ et al (2009) Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration. Soc Neurosci 4:359\u2013366","journal-title":"Soc Neurosci"},{"key":"4779_CR23","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.biopsych.2014.10.015","volume":"78","author":"M Eckstein","year":"2015","unstructured":"Eckstein M et al (2015) Oxytocin facilitates the extinction of conditioned fear in humans. Biol Psychiatry 78:194\u2013202. https:\/\/doi.org\/10.1016\/j.biopsych.2014.10.015","journal-title":"Biol Psychiatry"},{"key":"4779_CR24","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1176\/appi.ajp.2007.07030504","volume":"164","author":"A Etkin","year":"2007","unstructured":"Etkin A, Wager TD (2007) Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry 164:1476\u20131488. https:\/\/doi.org\/10.1176\/appi.ajp.2007.07030504","journal-title":"Am J Psychiatry"},{"key":"4779_CR25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.brainresbull.2008.07.007","volume":"77","author":"AA Feduccia","year":"2008","unstructured":"Feduccia AA, Duvauchelle CL (2008) Auditory stimuli enhance MDMA-conditioned reward and MDMA-induced nucleus accumbens dopamine, serotonin and locomotor responses. Brain Res Bull 77:189\u2013196. https:\/\/doi.org\/10.1016\/j.brainresbull.2008.07.007","journal-title":"Brain Res Bull"},{"key":"4779_CR26","unstructured":"Feduccia AA, Yazar-Klosinski B, Jerome L, Mithoefer MC, Emerson A, Doblin R (2016) MDMA-assisted Psychotherapy for Treatment of Chronic PTSD: Findings from MAPS-Sponsored Phase 2 Clinical Research Trials. Paper presented at the The 46th Annual Meeting of the Society for Neuroscience, San Diego, California"},{"key":"4779_CR27","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/0024-3205(80)90499-3","volume":"27","author":"BM Ferrier","year":"1980","unstructured":"Ferrier BM, Kennett DJ, Devlin MC (1980) Influence of oxytocin on human memory processes. Life Sci 27:2311\u20132317","journal-title":"Life Sci"},{"key":"4779_CR28","volume-title":"Effective treatments for PTSD: practice guidelines from the International Society for Traumatic Stress Studies vol","author":"EB Foa","year":"2009","unstructured":"Foa EB, Keane TM, Friedman MJ, Cohen JA (2009) Effective treatments for PTSD: practice guidelines from the International Society for Traumatic Stress Studies vol, 2nd edn. Guilford Press, New York","edition":"2"},{"key":"4779_CR29","doi-asserted-by":"publisher","first-page":"841","DOI":"10.4088\/JCP.12m08030","volume":"74","author":"JD Ford","year":"2013","unstructured":"Ford JD, Grasso D, Greene C, Levine J, Spinazzola J, van der Kolk B (2013) Clinical significance of a proposed developmental trauma disorder diagnosis: results of an international survey of clinicians. J Clin Psychiatry 74:841\u2013849. https:\/\/doi.org\/10.4088\/JCP.12m08030","journal-title":"J Clin Psychiatry"},{"key":"4779_CR30","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/j.1360-0443.2006.01511.x","volume":"101","author":"RW Freudenmann","year":"2006","unstructured":"Freudenmann RW, Oxler F, Bernschneider-Reif S (2006) The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents. Addiction 101:1241\u20131245","journal-title":"Addiction"},{"key":"4779_CR31","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0272-0590(87)90158-8","volume":"9","author":"CH Frith","year":"1987","unstructured":"Frith CH, Chang LW, Lattin DL, Walls RC, Hamm J, Doblin R (1987) Toxicity of methylenedioxymethamphetamine (MDMA) in the dog and the rat. Fundam Appl Toxicol 9:110\u2013119","journal-title":"Fundam Appl Toxicol"},{"key":"4779_CR32","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0893-133X(00)00130-5","volume":"23","author":"A Gamma","year":"2000","unstructured":"Gamma A, Buck A, Berthold T, Liechti ME, Vollenweider FX (2000) 3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H(2)(15)O]-PET in healthy humans. Neuropsychopharmacology 23:388\u2013395","journal-title":"Neuropsychopharmacology"},{"key":"4779_CR33","unstructured":"GlaxoSmithKline (2001) New Drug Application (NDA 20\u2013031\/S-029) Paxil (Paroxetine Hydrochloride) Tablets vol Posttraumatic Stress Disorder Volume 1"},{"key":"4779_CR34","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/02791072.1986.10472364","volume":"18","author":"G Greer","year":"1986","unstructured":"Greer G, Tolbert R (1986) Subjective reports of the effects of MDMA in a clinical setting. J Psychoactive Drugs 18:319\u2013327","journal-title":"J Psychoactive Drugs"},{"key":"4779_CR35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0955-3959(98)00008-5","volume":"9","author":"C Grob","year":"1998","unstructured":"Grob C (1998) MDMA research: preliminary investigations with human subjects. Int J Drug Policy 9:119\u2013124","journal-title":"Int J Drug Policy"},{"key":"4779_CR36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0166-4328(96)00078-2","volume":"73","author":"CS Grob","year":"1996","unstructured":"Grob CS, Poland RE, Chang L, Ernst T (1996) Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations. Behav Brain Res 73:103\u2013107","journal-title":"Behav Brain Res"},{"key":"4779_CR37","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.biopsych.2008.02.008","volume":"64","author":"AJ Guastella","year":"2008","unstructured":"Guastella AJ, Mitchell PB, Mathews F (2008) Oxytocin enhances the encoding of positive social memories in humans. Biol Psychiatry 64:256\u2013258. https:\/\/doi.org\/10.1016\/j.biopsych.2008.02.008","journal-title":"Biol Psychiatry"},{"key":"4779_CR38","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/75698","volume":"3","author":"J Hall","year":"2000","unstructured":"Hall J, Thomas KL, Everitt BJ (2000) Rapid and selective induction of BDNF expression in the hippocampus during contextual learning. Nat Neurosci 3:533\u2013535. https:\/\/doi.org\/10.1038\/75698","journal-title":"Nat Neurosci"},{"key":"4779_CR39","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2210-6-6","volume":"6","author":"DD Han","year":"2006","unstructured":"Han DD, Gu HH (2006) Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacol 6:6","journal-title":"BMC Pharmacol"},{"key":"4779_CR40","first-page":"331","volume":"28","author":"D Healy","year":"2003","unstructured":"Healy D, Whitaker C (2003) Antidepressants and suicide: risk-benefit conundrums. J Psychiatry Neurosci 28:331\u2013337","journal-title":"J Psychiatry Neurosci"},{"key":"4779_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.physbeh.2004.07.020","volume":"83","author":"M Heinrichs","year":"2004","unstructured":"Heinrichs M, Meinlschmidt G, Wippich W, Ehlert U, Hellhammer DH (2004) Selective amnesic effects of oxytocin on human memory. Physiol Behav 83:31\u201338. https:\/\/doi.org\/10.1016\/j.physbeh.2004.07.020","journal-title":"Physiol Behav"},{"key":"4779_CR42","doi-asserted-by":"publisher","first-page":"4999","DOI":"10.1523\/JNEUROSCI.5538-09.2010","volume":"30","author":"R Hurlemann","year":"2010","unstructured":"Hurlemann R et al (2010) Oxytocin enhances amygdala-dependent, socially reinforced learning and emotional empathy in humans. J Neurosci 30:4999\u20135007. https:\/\/doi.org\/10.1523\/JNEUROSCI.5538-09.2010","journal-title":"J Neurosci"},{"key":"4779_CR43","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00213-012-2645-9","volume":"222","author":"CM Hysek","year":"2012","unstructured":"Hysek CM, Domes G, Liechti ME (2012a) MDMA enhances \"mind reading\" of positive emotions and impairs \"mind reading\" of negative emotions. Psychopharmacology 222:293\u2013302. https:\/\/doi.org\/10.1007\/s00213-012-2645-9","journal-title":"Psychopharmacology"},{"key":"4779_CR44","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1093\/scan\/nst161","volume":"9","author":"CM Hysek","year":"2014","unstructured":"Hysek CM et al (2014a) MDMA enhances emotional empathy and prosocial behavior. Soc Cogn Affect Neurosci 9:1645\u20131652. https:\/\/doi.org\/10.1093\/scan\/nst161","journal-title":"Soc Cogn Affect Neurosci"},{"key":"4779_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036476","volume":"7","author":"CM Hysek","year":"2012","unstructured":"Hysek CM et al (2012b) Duloxetine inhibits effects of MDMA (\"ecstasy\") in vitro and in humans in a randomized placebo-controlled laboratory study. PLoS One 7:e36476. https:\/\/doi.org\/10.1371\/journal.pone.0036476","journal-title":"PLoS One"},{"key":"4779_CR46","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1017\/S1461145713001132","volume":"17","author":"CM Hysek","year":"2014","unstructured":"Hysek CM et al (2014b) Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination. Int J Neuropsychopharmacol 17:371\u2013381. https:\/\/doi.org\/10.1017\/S1461145713001132","journal-title":"Int J Neuropsychopharmacol"},{"key":"4779_CR47","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0306-4530(92)90073-G","volume":"17","author":"TR Insel","year":"1992","unstructured":"Insel TR (1992) Oxytocin\u2014a neuropeptide for affiliation: evidence from behavioral, receptor autoradiographic, and comparative studies. Psychoneuroendocrinology 17:3\u201335","journal-title":"Psychoneuroendocrinology"},{"key":"4779_CR48","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2174\/18744737112059990005","volume":"6","author":"L Jerome","year":"2013","unstructured":"Jerome L, Schuster S, Yazar-Klosinski BB (2013) Can MDMA play a role in the treatment of substance abuse? Curr Drug Abuse Rev 6:54\u201362","journal-title":"Curr Drug Abuse Rev"},{"key":"4779_CR49","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.neubiorev.2015.08.016","volume":"57","author":"P Kamilar-Britt","year":"2015","unstructured":"Kamilar-Britt P, Bedi G (2015) The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): controlled studies in humans and laboratory animals. Neurosci Biobehav Rev 57:433\u2013446. https:\/\/doi.org\/10.1016\/j.neubiorev.2015.08.016","journal-title":"Neurosci Biobehav Rev"},{"key":"4779_CR50","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1007\/s00213-014-3528-z","volume":"231","author":"MG Kirkpatrick","year":"2014","unstructured":"Kirkpatrick MG, Baggott MJ, Mendelson JE, Galloway GP, Liechti ME, Hysek CM, de Wit H (2014a) MDMA effects consistent across laboratories. Psychopharmacology 231:3899\u20133905. https:\/\/doi.org\/10.1007\/s00213-014-3528-z","journal-title":"Psychopharmacology"},{"key":"4779_CR51","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.psyneuen.2014.04.006","volume":"46","author":"MG Kirkpatrick","year":"2014","unstructured":"Kirkpatrick MG, Francis SM, Lee R, de Wit H, Jacob S (2014b) Plasma oxytocin concentrations following MDMA or intranasal oxytocin in humans. Psychoneuroendocrinology 46:23\u201331. https:\/\/doi.org\/10.1016\/j.psyneuen.2014.04.006","journal-title":"Psychoneuroendocrinology"},{"key":"4779_CR52","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1038\/npp.2014.12","volume":"39","author":"MG Kirkpatrick","year":"2014","unstructured":"Kirkpatrick MG, Lee R, Wardle MC, Jacob S, de Wit H (2014c) Effects of MDMA and intranasal oxytocin on social and emotional processing. Neuropsychopharmacology 39:1654\u20131663. https:\/\/doi.org\/10.1038\/npp.2014.12","journal-title":"Neuropsychopharmacology"},{"key":"4779_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100719","volume":"9","author":"KP Kuypers","year":"2014","unstructured":"Kuypers KP, de la Torre R, Farre M, Yubero-Lahoz S, Dziobek I, Van den Bos W, Ramaekers JG (2014) No evidence that MDMA-induced enhancement of emotional empathy is related to peripheral oxytocin levels or 5-HT1a receptor activation. PLoS One 9:e100719. https:\/\/doi.org\/10.1371\/journal.pone.0100719","journal-title":"PLoS One"},{"key":"4779_CR54","doi-asserted-by":"publisher","unstructured":"Kuypers KP, Dolder PC, Ramaekers JG, Liechti ME (2017) Multifaceted empathy of healthy volunteers after single doses of MDMA: A pooled sample of placebo-controlled studies J Psychopharmacol:269881117699617 doi: https:\/\/doi.org\/10.1177\/0269881117699617","DOI":"10.1177\/0269881117699617"},{"key":"4779_CR55","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0006-8993(86)91049-8","volume":"368","author":"KC Liang","year":"1986","unstructured":"Liang KC, Juler RG, McGaugh JL (1986) Modulating effects of posttraining epinephrine on memory: involvement of the amygdala noradrenergic system. Brain Res 368:125\u2013133","journal-title":"Brain Res"},{"key":"4779_CR56","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s002130000648","volume":"154","author":"ME Liechti","year":"2001","unstructured":"Liechti ME, Gamma A, Vollenweider FX (2001) Gender differences in the subjective effects of MDMA. Psychopharmacology 154:161\u2013168","journal-title":"Psychopharmacology"},{"key":"4779_CR57","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/026988110001400313","volume":"14","author":"ME Liechti","year":"2000","unstructured":"Liechti ME, Vollenweider FX (2000) The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers. J Psychopharmacol 14:269\u2013274","journal-title":"J Psychopharmacol"},{"key":"4779_CR58","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1017\/S1740925X05000232","volume":"1","author":"B Lu","year":"2004","unstructured":"Lu B, Chang JH (2004) Regulation of neurogenesis by neurotrophins: implications in hippocampus-dependent memory. Neuron Glia Biol 1:377\u2013384. https:\/\/doi.org\/10.1017\/S1740925X05000232","journal-title":"Neuron Glia Biol"},{"key":"4779_CR59","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0022-3565(24)34877-3","volume":"290","author":"M Mas","year":"1999","unstructured":"Mas M, Farre M, de la Torre R, Roset PN, Ortuno J, Segura J, Cami J (1999) Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans. J Pharmacol Exp Ther 290:136\u2013145","journal-title":"J Pharmacol Exp Ther"},{"key":"4779_CR60","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1093\/scan\/nss019","volume":"8","author":"ML Meyer","year":"2013","unstructured":"Meyer ML, Masten CL, Ma Y, Wang C, Shi Z, Eisenberger NI, Han S (2013) Empathy for the social suffering of friends and strangers recruits distinct patterns of brain activation. Soc Cogn Affect Neurosci 8:446\u2013454. https:\/\/doi.org\/10.1093\/scan\/nss019","journal-title":"Soc Cogn Affect Neurosci"},{"key":"4779_CR61","unstructured":"Mithoefer M MDMA-assisted psychotherapy; promising treatment for PTSD In: American Psychiatric Association Annual Meeting, Toronto, ON, 2015"},{"key":"4779_CR62","unstructured":"Mithoefer M (2017) A Manual for MDMA-Assisted Psychotherapy in the Treatment of Posttraumatic Stress Disorder; Version 8.1.\u00a0 https:\/\/s3-us-west-1.amazonaws.com\/mapscontent\/research-archive\/mdma\/TreatmentManual_MDMAAssistedPsychotherapyVersion+8.1_22+Aug2017.pdf"},{"key":"4779_CR63","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1177\/0269881110378371","volume":"25","author":"MC Mithoefer","year":"2011","unstructured":"Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Doblin R (2011) The safety and efficacy of {+\/\u2212}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. J Psychopharmacol 25:439\u2013452. https:\/\/doi.org\/10.1177\/0269881110378371","journal-title":"J Psychopharmacol"},{"key":"4779_CR64","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1177\/0269881112456611","volume":"27","author":"MC Mithoefer","year":"2013","unstructured":"Mithoefer MC et al (2013) Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study. J Psychopharmacol 27:28\u201339. https:\/\/doi.org\/10.1177\/0269881112456611","journal-title":"J Psychopharmacol"},{"key":"4779_CR65","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1080\/15563650.2016.1245421","volume":"54","author":"JB Mowry","year":"2016","unstructured":"Mowry JB, Spyker DA, Brooks DE, Zimmerman A, Schauben JL (2016) 2015 annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 33rd annual report. Clin Toxicol (Phila) 54:924\u20131109. https:\/\/doi.org\/10.1080\/15563650.2016.1245421","journal-title":"Clin Toxicol (Phila)"},{"key":"4779_CR66","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1124\/jpet.110.166595","volume":"334","author":"KS Murnane","year":"2010","unstructured":"Murnane KS, Fantegrossi WE, Godfrey JR, Banks ML, Howell LL (2010) Endocrine and neurochemical effects of 3,4-methylenedioxymethamphetamine and its stereoisomers in rhesus monkeys. J Pharmacol Exp Ther 334:642\u2013650. https:\/\/doi.org\/10.1124\/jpet.110.166595","journal-title":"J Pharmacol Exp Ther"},{"key":"4779_CR67","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.dcn.2012.04.003","volume":"2","author":"ED Musser","year":"2012","unstructured":"Musser ED, Kaiser-Laurent H, Ablow JC (2012) The neural correlates of maternal sensitivity: an fMRI study. Dev Cogn Neurosci 2:428\u2013436. https:\/\/doi.org\/10.1016\/j.dcn.2012.04.003","journal-title":"Dev Cogn Neurosci"},{"key":"4779_CR68","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1523\/JNEUROSCI.15-11-07539.1995","volume":"15","author":"M Nibuya","year":"1995","unstructured":"Nibuya M, Morinobu S, Duman RS (1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15:7539\u20137547","journal-title":"J Neurosci"},{"key":"4779_CR69","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/02791072.1986.10472362","volume":"18","author":"DE Nichols","year":"1986","unstructured":"Nichols DE (1986) Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens. J Psychoactive Drugs 18:305\u2013313","journal-title":"J Psychoactive Drugs"},{"key":"4779_CR70","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1177\/0269881112464827","volume":"27","author":"P Oehen","year":"2013","unstructured":"Oehen P, Traber R, Widmer V, Schnyder U (2013) A randomized, controlled pilot study of MDMA (+\/\u2212 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic post-traumatic stress disorder (PTSD). J Psychopharmacol 27:40\u201352. https:\/\/doi.org\/10.1177\/0269881112464827","journal-title":"J Psychopharmacol"},{"key":"4779_CR71","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s00213-012-2894-7","volume":"225","author":"AM Peiro","year":"2013","unstructured":"Peiro AM et al (2013) Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apart. Psychopharmacology 225:883\u2013893. https:\/\/doi.org\/10.1007\/s00213-012-2894-7","journal-title":"Psychopharmacology"},{"key":"4779_CR72","unstructured":"Pfizer (1999) New Drug Application Zoloft (sertraline)"},{"key":"4779_CR73","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.biopsych.2006.06.004","volume":"60","author":"SL Rauch","year":"2006","unstructured":"Rauch SL, Shin LM, Phelps EA (2006) Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research--past, present, and future. Biol Psychiatry 60:376\u2013382","journal-title":"Biol Psychiatry"},{"key":"4779_CR74","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1126\/science.1074501","volume":"297","author":"GA Ricaurte","year":"2002","unstructured":"Ricaurte GA, Yuan J, Hatzidimitriou G, Cord BJ, McCann UD (2002) Severe dopaminergic neurotoxicity in primates after a common recreational dose regimen of MDMA (\"ecstasy\"). Science 297:2260\u20132263. https:\/\/doi.org\/10.1126\/science.1074501","journal-title":"Science"},{"key":"4779_CR75","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1126\/science.301.5639.1479b","volume":"301","author":"GA Ricaurte","year":"2003","unstructured":"Ricaurte GA, Yuan J, Hatzidimitriou G, Cord BJ, McCann UD (2003) Retraction. Science 301:1479","journal-title":"Science"},{"key":"4779_CR76","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1523\/JNEUROSCI.4260-08.2009","volume":"29","author":"U Rimmele","year":"2009","unstructured":"Rimmele U, Hediger K, Heinrichs M, Klaver P (2009) Oxytocin makes a face in memory familiar. J Neurosci 29:38\u201342. https:\/\/doi.org\/10.1523\/JNEUROSCI.4260-08.2009","journal-title":"J Neurosci"},{"key":"4779_CR77","doi-asserted-by":"publisher","first-page":"6741","DOI":"10.1073\/pnas.0601874103","volume":"103","author":"B Roozendaal","year":"2006","unstructured":"Roozendaal B, Okuda S, Van der Zee EA, McGaugh JL (2006) Glucocorticoid enhancement of memory requires arousal-induced noradrenergic activation in the basolateral amygdala. Proc Natl Acad Sci U S A 103:6741\u20136746. https:\/\/doi.org\/10.1073\/pnas.0601874103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4779_CR78","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.psyneuen.2007.12.004","volume":"33","author":"E Savaskan","year":"2008","unstructured":"Savaskan E, Ehrhardt R, Schulz A, Walter M, Schachinger H (2008) Post-learning intranasal oxytocin modulates human memory for facial identity. Psychoneuroendocrinology 33:368\u2013374. https:\/\/doi.org\/10.1016\/j.psyneuen.2007.12.004","journal-title":"Psychoneuroendocrinology"},{"key":"4779_CR79","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1177\/0269881114542454","volume":"28","author":"Y Schmid","year":"2014","unstructured":"Schmid Y, Hysek CM, Simmler LD, Crockett MJ, Quednow BB, Liechti ME (2014) Differential effects of MDMA and methylphenidate on social cognition. J Psychopharmacol 28:847\u2013856. https:\/\/doi.org\/10.1177\/0269881114542454","journal-title":"J Psychopharmacol"},{"key":"4779_CR80","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/FPC.0000000000000231","volume":"26","author":"Y Schmid","year":"2016","unstructured":"Schmid Y, Vizeli P, Hysek CM, Prestin K, Meyer Z, Schwabedissen HE, Liechti ME (2016) CYP2D6 function moderates the pharmacokinetics and pharmacodynamics of 3,4-methylene-dioxymethamphetamine in a controlled study in healthy individuals. Pharmacogenet Genomics 26:397\u2013401. https:\/\/doi.org\/10.1097\/FPC.0000000000000231","journal-title":"Pharmacogenet Genomics"},{"key":"4779_CR81","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000364879","volume":"100","author":"J Seibert","year":"2014","unstructured":"Seibert J, Hysek CM, Penno CA, Schmid Y, Kratschmar DV, Liechti ME, Odermatt A (2014) Acute effects of 3,4-methylenedioxymethamphetamine and methylphenidate on circulating steroid levels in healthy subjects. Neuroendocrinology 100:17\u201325. https:\/\/doi.org\/10.1159\/000364879","journal-title":"Neuroendocrinology"},{"key":"4779_CR82","doi-asserted-by":"publisher","first-page":"e580","DOI":"10.4088\/JCP.15m09932","volume":"77","author":"AY Shalev","year":"2016","unstructured":"Shalev AY, Ankri Y, Gilad M, Israeli-Shalev Y, Adessky R, Qian M, Freedman S (2016) Long-term outcome of early interventions to prevent posttraumatic stress disorder. J Clin Psychiatry 77:e580\u2013e587. https:\/\/doi.org\/10.4088\/JCP.15m09932","journal-title":"J Clin Psychiatry"},{"key":"4779_CR83","volume-title":"The pharmacology of hallucinogens","author":"AT Shulgin","year":"1978","unstructured":"Shulgin AT, Nichols DE (1978) Characterization of three new psychotomimetics. In: Stillman RC, Willette RE (eds) The pharmacology of hallucinogens. Pergamon, New York"},{"key":"4779_CR84","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1503\/jpn.110069","volume":"37","author":"RK Sripada","year":"2012","unstructured":"Sripada RK, King AP, Garfinkel SN, Wang X, Sripada CS, Welsh RC, Liberzon I (2012) Altered resting-state amygdala functional connectivity in men with posttraumatic stress disorder. J Psychiatry Neurosci 37:241\u2013249. https:\/\/doi.org\/10.1503\/jpn.110069","journal-title":"J Psychiatry Neurosci"},{"key":"4779_CR85","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1001\/jama.2015.8370","volume":"314","author":"MM Steenkamp","year":"2015","unstructured":"Steenkamp MM, Litz BT, Hoge CW, Marmar CR (2015) Psychotherapy for military-related PTSD: a review of randomized clinical trials. JAMA 314:489\u2013500. https:\/\/doi.org\/10.1001\/jama.2015.8370","journal-title":"JAMA"},{"key":"4779_CR86","volume-title":"The secret chief revealed: conversations with a pioneer of the underground therapy movement","author":"M Stolaroff","year":"2004","unstructured":"Stolaroff M (2004) The secret chief revealed: conversations with a pioneer of the underground therapy movement. Multidisciplinary Association for Psychedelic Studies, Sarasota FL"},{"key":"4779_CR87","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1126\/science.270.5236.593","volume":"270","author":"H Thoenen","year":"1995","unstructured":"Thoenen H (1995) Neurotrophins and neuronal plasticity. Science 270:593\u2013598","journal-title":"Science"},{"key":"4779_CR88","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.neuroscience.2007.02.032","volume":"146","author":"MR Thompson","year":"2007","unstructured":"Thompson MR, Callaghan PD, Hunt GE, Cornish JL, McGregor IS (2007) A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine (\"ecstasy\"). Neuroscience 146:509\u2013514","journal-title":"Neuroscience"},{"key":"4779_CR89","doi-asserted-by":"publisher","first-page":"572","DOI":"10.13109\/prkk.2009.58.8.572","volume":"58","author":"BA Kolk van der","year":"2009","unstructured":"van der Kolk BA (2009) Developmental trauma disorder: towards a rational diagnosis for chronically traumatized children. Prax Kinderpsychol Kinderpsychiatr 58:572\u2013586. 10.13109\/prkk.2009.58.8.572","journal-title":"Prax Kinderpsychol Kinderpsychiatr"},{"key":"4779_CR90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040187","volume":"7","author":"JH Wel van","year":"2012","unstructured":"van Wel JH, Kuypers KP, Theunissen EL, Bosker WM, Bakker K, Ramaekers JG (2012) Effects of acute MDMA intoxication on mood and impulsivity: role of the 5-HT(2) and 5-HT(1) receptors. PLoS One 7:e40187. https:\/\/doi.org\/10.1371\/journal.pone.0040187","journal-title":"PLoS One"},{"key":"4779_CR91","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00213-005-0174-5","volume":"189","author":"CD Verrico","year":"2007","unstructured":"Verrico CD, Miller GM, Madras BK (2007) MDMA (ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment. Psychopharmacology 189:489\u2013503","journal-title":"Psychopharmacology"},{"key":"4779_CR92","doi-asserted-by":"publisher","unstructured":"Vizeli P, Liechti ME (2017) Safety pharmacology of acute MDMA administration in healthy subjects J Psychopharmacol:269881117691569 doi: https:\/\/doi.org\/10.1177\/0269881117691569","DOI":"10.1177\/0269881117691569"},{"key":"4779_CR93","volume-title":"Oakland","author":"AC Wagner","year":"2017","unstructured":"Wagner AC (2017) (2017) combining cognitive behavioral conjoint therapy for PTSD and MDMA - first cases and understanding the MDMA experience from a cognitive behavioral framework. In: psychedelic science 2017. In: Oakland"},{"key":"4779_CR94","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0149-7634(95)00006-Z","volume":"19","author":"DM Witt","year":"1995","unstructured":"Witt DM (1995) Oxytocin and rodent sociosexual responses: from behavior to gene expression. Neurosci Biobehav Rev 19:315\u2013324","journal-title":"Neurosci Biobehav Rev"},{"key":"4779_CR95","unstructured":"Wolfson P (2015) Return to ADAM: reflections on MDMA-assisted psychotherapy 30 years later. MAPS Bulletin, Vol 25(3).\u00a0 http:\/\/www.maps.org\/news\/bulletin\/articles\/389-bulletin-winter-2015\/5923-return-to-adam-reflections-on-mdma-assisted-psychotherapy-30-years-later"},{"key":"4779_CR96","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/cpt.565","volume":"101","author":"BB Yazar-Klosinski","year":"2017","unstructured":"Yazar-Klosinski BB, Mithoefer MC (2017) Potential psychiatric uses for MDMA. Clin Pharmacol Ther 101:194\u2013196. https:\/\/doi.org\/10.1002\/cpt.565","journal-title":"Clin Pharmacol Ther"},{"key":"4779_CR97","doi-asserted-by":"publisher","DOI":"10.3402\/ejpt.v7.33768","volume":"7","author":"R Yehuda","year":"2016","unstructured":"Yehuda R, Spiegel D, Southwick S, Davis LL, Neylan TC, Krystal JH (2016) What I have changed my mind about and why. Eur J Psychotraumatol 7:33768. https:\/\/doi.org\/10.3402\/ejpt.v7.33768","journal-title":"Eur J Psychotraumatol"},{"key":"4779_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.138","volume":"5","author":"MB Young","year":"2015","unstructured":"Young MB, Andero R, Ressler KJ, Howell LL (2015) 3,4-Methylenedioxymethamphetamine facilitates fear extinction learning. Transl Psychiatry 5:e634. https:\/\/doi.org\/10.1038\/tp.2015.138","journal-title":"Transl Psychiatry"},{"key":"4779_CR99","doi-asserted-by":"publisher","unstructured":"Young MB et al. (2017) Inhibition of serotonin transporters disrupts the enhancement of fear memory extinction by 3,4-methylenedioxymethamphetamine (MDMA) psychopharmacology (Berl) doi: https:\/\/doi.org\/10.1007\/s00213-017-4684-8","DOI":"10.1007\/s00213-017-4684-8"},{"key":"4779_CR100","doi-asserted-by":"crossref","unstructured":"Yubero-Lahoz S et al. (2012) Changes in CYP1A2 activity in humans after 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) administration using caffeine as a probe drug Drug Metab Pharmacokinet 27:605\u2013613 doi:DN\/JST.JSTAGE\/dmpk\/DMPK-12-RG-032 [pii]","DOI":"10.2133\/dmpk.DMPK-12-RG-032"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-017-4779-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-017-4779-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-017-4779-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T04:40:50Z","timestamp":1750999250000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-017-4779-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,20]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["4779"],"URL":"https:\/\/doi.org\/10.1007\/s00213-017-4779-2","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,20]]}}}